DAMORA THERAPEUTICS, INC. (DMRA) Operating income 2019–2025
DAMORA THERAPEUTICS, INC. (DMRA) annual operating income history from SEC filings — each fiscal year as reported.
-$210.9MFY2025 · since FY2019: $39.0M → -$210.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$210.9M | -847.3% |
| FY2024 | -$22.3M | +44.2% |
| FY2023 | -$39.9M | +34.8% |
| FY2022 | -$61.2M | -17.2% |
| FY2021 | -$52.2M | -55.3% |
| FY2020 | -$33.6M | -186.3% |
| FY2019 | $39.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice